The androgen receptor (AR), a member of the nuclear receptor superfamily, plays a central role in male sexual differentiation and prostate cell proliferation. Results of treating prostate cancer by androgen ablation indicate that signals mediated through AR are critical for the growth of these tumors. Like other nuclear receptors, AR exerts its transcriptional function by binding to ciselements upstream of promoters and interacting with other transcriptional factors (e.g., activators, repressors and modulators). To determine the mechanism of AR-regulated transcription, we used the yeast two-hybrid system to identify AR-associated proteins. One of the proteins we identified is identical to the human origin recognition complex (ORC1)-interacting protein termed HBO1. A ligand-enhanced interaction between AR and HBO1 was further confirmed in vivo and in vitro.
INTRODUCTION
The androgen receptor (AR), as a member of the superfamily of ligand-dependent nuclear receptors, plays a central role in male sexual development and in normal and malignant prostate cell proliferation (1) (2) (3) (4) . Ligand-dependent nuclear receptors typically contain three domains: a carboxyterminal ligand-binding domain (LBD), an amino-terminal transactivation domain (TAD), and a DNA binding domain (DBD) located between the LBD and TAD. Another transactivation domain, termed AF-2, is present in the LBD of most steroid hormone receptors (5, 6 ), but has not been clearly defined for the AR (7, 8) . The AR, and other receptors in this family, forms a complex with heatshock proteins (HSPs) before exposure to the ligand, which appears to sequester the unbound AR (9) (10) (11) . Upon binding to ligand, the AR dissociates from the HSPs and translocates to the nucleus, where it binds to the androgen response element (ARE) and recruits cofactors to regulate transcription (12, 13) . Recent evidence suggests that upon ligand binding there may also be an interaction between the LBD and TAD which contributes to transactivation (14) .
Ligand-dependent nuclear receptors function by directly or indirectly interacting with other regulatory proteins in cells (see review by Xu et al. (15) ). Several co-activators have been identified that bind to the nuclear hormone receptors to modulate their transcription (16) (17) (18) (19) . A group of AR associated proteins, termed ARA24 (20) , ARA54 (21), ARA55 (22) , ARA70 (23) and ARA160 (24) , have been identified by yeast two hybrid screening and shown to modulate AR transcriptional activation. Interactions with CBP/p300 (25, 26) , AP-1 (27, 28) , cylin D1 (29), Stat 5 (30) and a fos containing complex (31) appear to directly couple AR and other related steroid hormone receptors to other pathways. A novel RING finger protein and a testis-specific nuclear protein were also found incubated with radiolabeled HBO1 or AR proteins at 4 o C for 2 hr in the modified NETN buffer (0.2% NP-40, 1mM EDTA, 20mM Tris-Cl, 100mM NaCl, 5% glycerol, 20µM ZnCl2, 4mM
MgCl2, 0.5mM DTT, 1mM PMSF, and 10µg/ml Aprotinin). Beads were carefully washed 4 times in NETN buffer and then analyzed by SDS-PAGE followed by autoradiography.
Immunoprecipitation and Western Blotting:
The human AR expression vector pARo, alone or with a Flag-tagged pCDNA3/HBO1 expression plasmid, was transfected into CV-1 cells.
Transfected cells were cultured in the presence of 10 nM R1881 for 48 hr and then harvested in a buffer containing 20mM HEPES (pH8.0), 0.5% NP-40, 100 mM NaCl, 1mM EDTA, 5mM MgCl 2 , 1mM CaCl 2 , 10µM ZnCl 2 , 1mM DTT, 1mM PMSF, 5µg/ml Leupeptin, and 5% glycerol). Whole cell lysates were incubated with mouse normal IgG or Flag monoclonal antibody (Sigma, St Louis, MO) at 4 o C for 2 hr. Pre-equilibrated Protein-A Sepharose beads were then added and, after an hour of incubation, collected by centrifugation and gently washed 3 times with the same buffer as described above. Specific protein complexes were eluted by 100ng/ml of Flag peptide in a buffer containing 10mM HEPES, 100mM NaCl, 1mM EDTA, and 0.1% NP-40. The eluted samples were boiled in SDS-sample buffer and resolved on a 10% SDS-PAGE. The proteins were transferred onto a nitrocellulose membrane and probed with 1: 200 dilution of a polyclonal antibody against the N-terminus of AR (Santa Cruz Biotech, Santa Cruz, CA, Cat# sc-816). Proteins were detected using ECL kit (Amersham, Arlington Heights, IL).
Cell Cultures and Transient Transfections:
Both a monkey kidney cell line, CV-1, and a human prostate cell line, PC-3, were maintained in RPMI media supplemented with 10% fetal calf serum (HyClone, Denver, CO). Transient transfections were carried out by using a LipofectAMINE transfection kit (GIBCO/BRL, Gaithersburg, MD). Approximately 3x10 4 cells were plated in a 24-well plate 16 hr before transfection. About 400 ng of total plasmid DNA per well were used in the transfection. The total amount of plasmid per dish was kept constant by adding pcDNA3 empty vector. Approximately 16 hr after transfection the cells were washed and fed medium containing 10% charcoal-stripped (steroid hormone free) fetal calf serum (HyClone, Denver, CO) in the by guest on October 29, 2017 http://www.jbc.org/ Downloaded from presence or absence of steroid hormones. Cells were incubated for another 24 hr and luciferase activity was measured as relative light units (RLU) as previously described (51) . The RLU from individual transfections were normalized by β-galactosidase activity in the same samples. Individual transfection experiments were done in triplicate and the results are reported as mean RLU/β-galactosidase (+SD) from representative experiments.
RESULTS

HBO1 interacts with the AR in yeast:
To identify AR interacting proteins, we screened a human prostate library with a GAL4 DBD fusion encoding the DBD and LBD of AR. Of 2x10 6 transformants, 75 positive clones were identified by both adenine and β-galactosidase production in the presence of DHT. Sequence analysis revealed that one of these clones (PG159) is identical to the C-terminus of a recently identified novel protein (GeneBank Accession Number AF074606), named HBO1 (Histone acetyltransferase Binding to the Origin recognition complex 1) (35) . To confirm this interaction, we transformed the PG159 clone with various constructs containing either GAL4DBD alone, or fusion proteins with different fragments derived from AR ( Fig 1A) . On the adenine minus plate, yeast colonies were only observed in the samples transformed with PG159 and GAL4DBD-AR fusion construct containing both the DBD and LBD in the presence of androgen (data not shown). There were no colonies observed in the transformants with other AR fusions. Liquid β-gal assay was performed to quantify the interactions. Constructs containing the GAL4 activation domain (AD) and either the C-terminal HBO1 or ARA70 (23) , an AR coactivator, showed a strong induction with the AR-DBD-LBD in the presence of DHT. An AR-LBD construct also showed an increase in β-gal in the presence of DHT (Fig.1B) . These results imply that HBO1 protein interacts with AR LBD in the presence of DHT, and that the interaction is more pronounced in the presence of the DBD.
HBO1 is a new member of the MYST superfamily. It contains a unique N-terminal serinerich region and the conserved C-terminal region with a C2HC zinc finger and putative by guest on October 29, 2017 http://www.jbc.org/ acetyltransferase domain (Fig 2) . To generate the full-length HBO1 cDNA, primers were designed to amplify the N-terminal fragment of HBO1. A 0.7Kb fragment was generated from the Marathon Ready cDNA libraries derived from human prostate tissues that perfectly matched the published sequence of HBO1 (35) . Comparison of the C-termini of Tip 60 and HBO1 revealed significant sequence identity (Fig. 2 ).
HBO1 interacts with AR in vitro & in vivo:
To verify the interaction observed in the yeast two-hybrid system, GST pull-down experiments were carried out with a series of GST-AR fusion proteins (31). 35 S-methionine labeled full-length HBO1 protein bound to GST-AR fusion proteins was analyzed by SDS-PAGE and detected by autoradiography. As seen in Figure 3A , a strong retention of HBO1 protein was specifically observed for the samples with GST-AR containing both the DBD and LBD (505-919 amino acids) in the presence of DHT. A weak interaction was also observed for the full LBD (676-919 amino acids), but not with AR-AD (1-563 amino acids), DBD (505-676 amino acids), and GST or beads alone. Using two additional GST-AR fusion proteins consisting of the partial LBD (676-844 amino acids) and AF2 truncated mutants (875-919 amino acids), we further determined that the full length LBD is required for the interaction (Fig. 3A, right panel). In these experiments, the interactions were not significantly affected by adding DHT (data not shown). These results are consistent with those of the yeast-two hybrid experiments and suggest that both the DBD and LBD of AR are required for the interaction with HBO1.
To map the interaction region of HBO1 protein, GST pull-down experiments were repeated with GST-HBO1 fusion proteins containing the N-terminal (1-360 amino acids) or C-terminal domains (230-611 amino acids). As shown in figure 3B , the C-terminus of HBO1 strongly HBO1 is a nuclear protein and highly expressed in human testis: Northern blot analysis was carried out to detect the expression of HBO1 in human tissues with a specific probe covering the first 234 amino acid residues of HBO1 protein. A 3.6 Kb transcript of HBO1 was detected ubiquitously in various tissues but most abundantly in testis (Fig. 4A ). In contrast, Iizuka & Stillman recently reported that HBO1 was highly expressed in ovarian tissue (35) . To address this issue, the Northern-blot analysis was repeated following the conditions described in the previous report. Again, we found that HBO1 is highly expressed in human testis (data not shown).
We also performed Northern blot analysis on RNA samples isolated from several prostate cancer cell lines, including AR-positive cells (LNCaP, MDA PCa 2a and MDA PCa 2b) and ARnegative cells (PC-3 and TSU) (Fig. 4B ). Using the same DNA probe as above, a 3.6 kb transcript of HBO1 was consistently detected in all cell lines tested (Fig. 4B ).
To determine whether the AR-HBO1 interaction takes place upon AR translocation into the nucleus, immunofluorescence assays were performed to examine the subcellular localization of HBO1 protein. As shown in Figure 4C , the HBO1 protein is exclusively localized in the nuclei of transfected CV-1 and PC-3 cells. To determine whether the nuclear location of HBO1 is regulated by androgen, the experiments were repeated in the presence or absence of DHT. There was no difference in HBO1 localization. In contrast, as previously reported by others, nuclear translocation of AR was observed in cells transfected with an AR expression vector in the presence of DHT (data not shown).
HBO1 represses transcription upon fusion to a heterologous DNA binding protein:
Potential functional domains of HBO1 include a unique N-terminal serine-rich region and a common C-terminal MYST domain (Fig.2) . To investigate possible effects of HBO1 on transcription, fragments containing the N-terminal (1-360 amino acids) or C-terminal domains (230-611 amino acids) of HBO1 were targeted to DNA by fusion with the GAL4 DBD (53) . These constructs were then tested for their ability to modulate transcription from a minimal promoter, derived from the chicken myelomonocytic growth factor gene (-41 to +61), driving transcription from a luciferase reporter gene (Luc reporter) (54) .
Limited induction of the GAL4/Luc reporter versus the Luc reporter was observed upon cotransfection of a plasmid carrying the GAL4 DBD alone (Fig.5) , consistent with earlier evidence of a previously described cryptic transcriptional activation domain between amino acids 97 and 147 of the GAL4 DBD (55) . Fusion of the GAL4 DBD to full length HBO1 showed slight repression of this induction. Moreover, activation by the GAL4 DBD was inhibited by more than 70% upon fusion with the N-terminal region of HBO1, suggesting that there is an intrinsic repression domain within this region of HBO1. In contrast, there was no effect when the C-terminal domain of HBO1 was used, which is consistent with the previous results that showed no intrinsic transcriptional activity from the MYST domain of Tip60 (52) . Ligand-dependent AR activation was repressed by more than 60% by co-transfection of the HBO1 expression construct at AR-HBO1 plasmid ratios of 1:4 (Fig.6A) . In contrast, co-transfection with ARA70, an AR co-activator, showed more than a 3-fold induction (Fig.6A) . The repression by HBO1 was not associated with a change in the intracellular steady state level of AR protein (data not shown), suggesting that repression resulted from direct effects on AR transactivation of its target promoter and not on down-regulation of AR expression.
To confirm the repression of AR activity by HBO1, transient transfections were repeated in CV1 cells with a luciferase reporter driven by the human prostate specific antigen (PSA) promoter which is solely regulated by AR and has been widely used to analyze AR-mediated transcription activity (13) . A similar inhibitory effect of HBO1 was observed in these experiments (Fig. 6B) . To further evaluate the functional interaction of AR and HBO1 in a physiologically relevant cellular context, transient transfections were repeated in PC-3 cells, a human prostate cancer cell line. As shown in Figure 6C , the ligand dependent induction by AR was repressed by co-transfection of HBO1 in PC-3 cells.
To map the repression domains of HBO1 in the AR mediated transcription, both the N-and Cterminal regions of HBO1 were transfected into CV-1 cells. Like the full length HBO1 protein, the N-terminal domain of HBO1 repressed AR-induced activation (Fig. 6D) , which was consistant with the transcriptional inhibition by this domain when fused to the GAL4 DBD (Fig. 5) . In contrast, the C-terminal region was shown no significant effect.
In view of the previous study showing that a truncated Tip60 protein functions as a coactivator for AR, ER, and PR (52), our finding that HBO1 represses AR-mediated transcription was quite surprising. To assess Tip60 transcriptional activity in our system, an expression vector As shown in Fig. 6D , Tip60 repressed AR-mediated induction, similar to that of HBO1. The differences between our results and those previously published are probably due to the use of full length versus truncated Tip60 proteins. To ensure that HBO1-mediated inhibition did not reflect toxic or other nonspecific effects of the co-transfected plasmids, luciferase expression from the above experiments was normalized using β-galactosidase production from a co-transfected plasmid in all the experiments (Fig.6) .
Finally, we asked whether HBO1 could repress transcription mediated by other nuclear receptors. A human estrogen receptor (ER) or thyroid hormone receptor (TR) expression plasmid was co-transfected with the HBO1 expression vector and the respective luciferase reporters in CV1 cells. In contrast to the observed suppression of AR-mediated transcription, HBO1 had no inhibitory effect on either ER-or TR-mediated transcription (Fig. 6E & F) .
DISCUSSION
The results described here demonstrate that the AR interacts with HBO1, a new member of the MYST subfamily of proteins (35) . The LBD and DBD of AR are required for this interaction.
When bound to AR, HBO1 represses transcription from AR element containing promoters. The transcriptional repression domain was determined to be in the N-terminal region of HBO1, which contains a serine-rich domain. HBO1 protein is exclusively localized in the nucleus, consistent with a role in regulating transcription. Like most nuclear receptor co-factors, HBO1 is ubiquitously expressed, but it is expressed at particularly high levels in testis tissues. Since HBO1 was originally identified through its interaction with the human ORC, it appears that HBO1 has important roles in both DNA replication and transcription.
Others have shown that another member of the MYST subfamily, Tip60, also interacts with AR (52). Tip60 was originally identified as an interacting protein of Tat, a transcription activator of were identified as AR-interacting proteins using the yeast two-hybrid system. We have further confirmed that the interaction between HBO1 and AR occurs in vivo by co-immunoprecipitation of these two proteins from mammalian cell lysates. Both HBO1 and Tip60 proteins showed a stronger interaction with the DBD-LBD domains of AR than with the LBD domain alone. Androgen enhances the interaction, suggesting that conformational changes in the LBD upon binding to ligand are necessary for this interaction. Using GST-pulldown assays, we further showed the C-terminal region of HBO1 mediates binding to the AR. Sequence analysis showed no LXXLL motif in this region, suggesting other unidentified motifs may contribute the interaction. In this regard, it will be interesting to determine whether other MYST subfamily members interact with AR.
In this study, we determined that the binding of both HBO1 and Tip60 to AR leads to repression of AR-mediated transcriptional activation. The repressor effect was unexpected, especially given a previous report indicating that Tip60 was an AR co-activator (52) . The Tip60 clone used in those previous studies lacked the N-terminal 70 amino acids, which may be potentially important for the transcriptional repression function. We know from our studies that the repression function is most active when a truncated HBO1 containing only the first 360 amino acids is used, and that deletion of the first 230 amino acids totally abrogates the repression activity of HBO1.
Thus, our finding that Tip60 acts as a transcriptional repressor may be due to the presence of the Nterminal 70 amino acids in the full-length clone used here. Many transcription factors and coactivators contain cryptic functional domains that are uncovered when deletion mutants are studied (51, 54, (56) (57) (58) . We believe that this is the case for Tip60; the transcription co-activation function was a result of the deletion of part of the repression domain. Further work with deletion mutants will be needed to confirm this possibility. We found that HBO1 probably does not act broadly as a nuclear hormone receptor co-factor, as it repressed AR-dependent promoter activity but not activities dependent on ER or TR. We have not tested all possibilities, so it is possible that HBO1 repressor activity will not be limited to the AR.
Studies using the truncated Tip60 protein (52) indicated that it functioned as a co-activator for all nuclear hormone receptors tested (AR, ER and PR). Whether this will be true when the full-length protein is used is currently unclear. While it is clear that members of the MYST subfamily of proteins are involved as co-factors to regulate transcription from genes dependent on a number of nuclear hormone receptors, much more work needs to be done to determine the whole spectrum of Zinc Fingers * * * * * * * * * * **** * * ** *** **** * * ** ** **** **** ** ** ** * * *** * ** ****** *** ******* * ******** * * * *** **** * * ** **** * * * ** * * * *** **** * * * ** * ****** *** *** * * * * *** * * **** * * ** * * ** * ** ** I n p u t Figure 6 
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